115PHGCSG1301: A multicenter, double-blind, randomized control phase II trial comparing Hange-shashin-to versus placebo to prevent diarrhea in patients with metastatic colorectal cancer under IRIS/Bev second-line treatment. (25th November 2018) - Dazai, M; Yuki, S; Sawada, K; Muranaka, T; Kawamoto, Y; Nakatsumi, H; Nakano, S; Ishiguro, A; Tateyama, M; Sato, A; Kobayashi, Y; Nakamura, M; et al.